RT Journal Article
SR Electronic
T1 Role of Weather Factors in COVID-19 Death Growth Rates in Tropical Climate: A Data-Driven Study Focused on Brazil Manuscript
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.13.20193532
DO 10.1101/2020.09.13.20193532
A1 Rahul Kalippurayil Moozhipurath
YR 2020
UL http://medrxiv.org/content/early/2020/10/05/2020.09.13.20193532.abstract
AB Background Brazil reported 123,780 deaths across 27 administrative regions, making it the second-worst affected country after the US in terms of COVID-19 deaths as of 3 September 2020. Understanding the role of weather factors in COVID-19 in Brazil is helpful in the long-term mitigation strategy of COVID-19 in other tropical countries because Brazil experienced early large-scale outbreak among tropical countries. Recent COVID-19 studies indicate that relevant weather factors such as temperature, humidity, UV Index (UVI), precipitation, ozone, pollution and cloud cover may influence the spread of COVID-19. Yet, the magnitude and direction of those associations remain inconclusive. Furthermore, there is only limited research exploring the impact of these weather factors in a tropical country like Brazil. In this observational study, we outline the roles of 7 relevant weather factors including temperature, humidity, UVI, precipitation, ozone, pollution (visibility) and cloud cover in COVID-19 death growth rates in Brazil.Methods We use a log-linear fixed-effects model to a panel dataset of 27 administrative regions in Brazil across 182 days (n=3882) and analyze the role of relevant weather factors by using daily cumulative COVID-19 deaths in Brazil as the dependent variable. We carry out robustness checks using case-fatality-rate (CFR) as the dependent variable.Findings We control for all region-specific time-fixed factors as well as potentially confounding time-varying factors. We observe a significant negative association of COVID-19 daily deaths growth rate in Brazil with weather factors - UVI, temperature, ozone and cloud cover. Specifically, a unit increase in UVI, maximum temperature, and ozone level independently associate with 6.0 percentage points [p<0.001], 1.8 percentage points [p<0.01] and 0.3 percentage points [p<0. 1] decline in COVID-19 deaths growth rate. Further, a percentage point increase in cloud cover associates with a decline of 0.148 percentage points [p<0.05] in COVID-19 deaths growth rate. Surprisingly, contrary to other studies, we do not find evidence of any association between COVID-19 daily deaths growth rate and humidity, visibility and precipitation. We find our results to be consistent even when we use the CFR as the dependent variable.Interpretation We find independent protective roles of UVI, temperature, ozone and cloud cover in mitigating COVID-19 deaths growth rate, even in a tropical country like Brazil. We observe these results to be consistent across various model specifications, especially for UVI and cloud cover, even after incorporating additional time-varying weather parameters such as dewpoint, pressure, wind speed and wind gust. These results could guide health-related policy decision making in Brazil as well as similar tropical countries.Competing Interest StatementRKM is a PhD student at Goethe University, Frankfurt. He is a full-time employee of a multinational chemical company involved in vitamin D business and holds the shares of the company. This study is intended to contribute to the ongoing COVID-19 crisis and is not sponsored by his company. The views expressed in the paper are those of the authors and do not represent that of any organization. No other relationships or activities that could appear to have influenced the submitted work.Funding StatementThis study is not sponsored by any organisation. The corresponding author had full access to all the data and had final responsibility for the submission decision.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Not applicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used in the study are sourced from publicly available sources. Data regarding COVID-19 are obtained on 25 August 2020 from the data released by the Ministry of Health, Brazil and can be accessed at https://covid.saude.gov.br/. Interested researchers can contact Rahul Kalippurayil Moozhipurath via email to get access to the data.